LABELLED CYTOKININS
[15N5]ADENINE (15N-Ade) [6-amino[15N5]purine]
| MW 140.10;
crystalline; purity > 97% (HPLC) |
CAS: 77910-29-3; C5H515N5
|
|
| 030
0241 |
1 |
mg |
| 030
0242 |
2
|
mg |
| 030
0243 |
5
|
mg |
[2H7]N6-BENZYLADENINE (D-BA) [6-[2H7]benzylaminopurine]
| MW 232.29;
crystalline; purity > 97% (HPLC) |
|
CAS: 147028-87-3; C12H42H7N5 |
|
| 030
0221 |
1 |
mg |
| 030
0222 |
2
|
mg |
| 030
0223 |
5
|
mg |
[2H7]N6-BENZYLADENOSINE (D-BAR) [6-[2H7]benzylamino-9-β-D-ribofuranosylpurine]
| MW 364.41;
crystalline; purity > 97% (HPLC) |
|
C17H122H7N5O4 |
|
| 030
0551 |
1 |
mg |
| 030
0552 |
2
|
mg |
| 030
0553 |
5
|
mg |
[2H7]N6-BENZYLADENINE-9-GLUCOSIDE (D-BA9G) [6-[2H7]benzylamino-9-β-D-glucopyranosylpurine]
| MW 394.44;
crystalline; purity > 97% (HPLC) |
|
C18H142H7N5O5 |
|
| 030
3281 |
1 |
mg |
| 030
3282 |
2
|
mg |
| 030
3283 |
5
|
mg |
[2H7]N6
- BENZYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (D-BAMP)
[6-[2H7]benzylamino-9-β-D-ribofuranosylpurine-5'-monophosphate
disodium monohydrate]
| MW 506.38;
crystalline; purity > 95% (HPLC) |
|
C17H112H7N5Na2O7P.H2O |
|
| 030
5001 |
1 |
mg |
| 030
5002 |
2
|
mg |
| 030
5003 |
5
|
mg |
[2H3]DIHYDROZEATIN (D-DHZ) [6-[2H3](4-hydroxy-3-methylbutylamino)purine]
| MW 224.28; crystalline; purity > 98% (HPLC) |
|
CAS: 175733-30-9; C10H122H3N5O |
|
| 030
0601 |
1 |
mg |
| 030
0602 |
2
|
mg |
| 030
0603 |
5
|
mg |
[15N-N4]DIHYDROZEATIN (15N-DHZ) [6-[15N-N4](4-hydroxy-3-methylbutylamino)purine]
| MW 225.24; crystalline; purity > 98% (HPLC) |
|
C10H12N15N4O |
|
| 030
7021 |
1 |
mg |
| 030
7022 |
2
|
mg |
| 030
7023 |
5
|
mg |
[2H3]DIHYDROZEATIN RIBOSIDE (D-DHZR)[6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosylpurine]
| MW 356.40;
crystalline; purity > 97% (HPLC) |
|
CAS: 175733-31-0; C15H202H3N5O5 |
|
| 030
0611 |
1 |
mg |
| 030
0612 |
2 |
mg |
| 030
0613 |
5 |
mg |
[2H3]DIHYDROZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-DHZMP) [6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl purine-5'-monophosphate disodium monohydrate]
| MW 498.36; crystalline; purity > 95% (HPLC) |
|
C15H192H3N5Na2O8P.H2O |
|
| 030
5011 |
1 |
mg |
| 030
5012 |
2
|
mg |
| 030
5013 |
5 |
mg |
[2H3]DIHYDROZEATIN-9-GLUCOSIDE (D-DHZ9G)[6-[2H3](4-hydroxy-3-methylbutylamino)-9-β-D-glucopyranosylpurine]
| MW 386.43; crystalline; purity > 95% (HPLC) |
|
C16H222H3N5O6 |
|
| 030
0631 |
1 |
mg |
| 030
0632 |
2 |
mg |
| 030
0633 |
5 |
mg |
[2H7]DIHYDROZEATIN-O-GLUCOSIDE (D-DHZOG) [6-[2H7](4-hydroxy-3-methylbytylamino)-O-β-D-glucopyranosylpurine]
| MW 390.45;
crystalline; purity > 95% (HPLC) |
|
C16H182H7N5O6 |
|
| 030
0641 |
100 |
µg |
| 030
0642 |
200 |
µg |
| 030
0643 |
500 |
µg |
[2H7]DIHYDROZEATIN-O-GLUCOSIDE RIBOSIDE (D-DZROG) [6-[2H7](4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl-O-β-D-glucopyranosylpurine]
| MW 522.47;
crystalline; purity > 95% (HPLC) |
|
C21H262H7N5O10 |
|
| 030
0651 |
100 |
µg |
| 030
0652 |
200 |
µg |
| 030
0653 |
500 |
mg |
[15N-N4]HYPOXANTINE (15N-Hyp) [6-[15N-N4]hydroxypurine]
| MW 140.09; crystalline; purity > 97% (HPLC) |
|
C5H415N4O |
|
| 030
5941 |
1 |
mg |
| 030
5942 |
2
|
mg |
| 030
5943 |
5
|
mg |
[2H6]N6-ISOPENTENYLADENINE (D-iP) [6-[2H6](3,3-dimethylallylamino)purine]
| MW 209.29; crystalline; purity > 98% (HPLC) |
|
CAS: 175733-28-5; C10H72H6N5 |
|
| 030
0161 |
1 |
mg |
| 030
0162 |
2 |
mg |
| 030
0163 |
5 |
mg |
[15N4-N6]-ISOPENTENYLADENINE (15N4-iP) [6-[15N4](3,3-dimethylallylamino)purine]
| MW 207.22;
crystalline; purity > 98% (HPLC) |
C10H1315N4N
|
|
| 030
7371 |
1 |
mg |
| 030
7372 |
2 |
mg |
| 030
7373 |
5 |
mg |
[2H6]N6-ISOPENTENYLADENOSINE (D-iPR) [6-[2H6](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]
| MW 341.41; crystalline; purity > 98% (HPLC) |
CAS: 175733-29-6; C15H152H6N5O4
|
|
| 030
0171 |
1 |
mg |
| 030
0172 |
2 |
mg |
| 030
0173 |
5 |
mg |
[15N]N6-ISOPENTENYLADENOSINE (15N-iPR) [6-[15N](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]
| MW 336.36;
crystalline; purity > 98% (HPLC) |
C15H21N415NO4
|
|
| 030
7031 |
1 |
mg |
| 030
7032 |
2 |
mg |
| 030
7033 |
5 |
mg |
[2H6]N6-ISOPENTENYLADENOSINE-5'-MONOPHOSPHATE (D-iPMP) [6[2H6]-(3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]
| MW 483.37;
crystalline; purity > 95% (HPLC) |
|
C15H142H6N5Na2O7P.H2O |
|
| 030
5041 |
1 |
mg |
| 030
5042 |
2 |
mg |
| 030
5043 |
5 |
mg |
[2H6]N6-ISOPENTENYLADENINE-7-GLUCOSIDE(D-iP7G)[6-[2H6] (3,3-dimethylallylamino)-7-β-D-glucopyranosylpurine]
| MW 371.43; crystalline; purity > 95% (HPLC) |
|
C16H172H6N5O5 |
|
| 030
5051 |
1 |
mg |
| 030
5052 |
2 |
mg |
| 030
5053 |
5 |
mg |
[2H6]
N6-ISOPENTENYLADENINE-9-GLUCOSIDE
(D-iP9G) [6-[2H6]
(3,3-dimethylallylamino)-9-β-D-glucopyranosylpurine]
| MW 371.43; crystalline; purity > 95% (HPLC) |
|
C16H172H6N5O5 |
|
| 030
0231 |
1 |
mg |
| 030
0232 |
2
|
mg |
| 030
0233 |
5
|
mg |
[2H6]2-METHYLTHIO-N6-ISOPENTENYLADENINE (D-2MeSiP) [2-methylthio-6-[2H6](3,3-dimethylallylamin)purine]
| MW 255.38;
crystalline; purity > 95% (HPLC) |
|
CAS: 1258839-11-0; C10H72H6N5S |
|
| 030
5071 |
1 |
mg |
| 030
5072 |
2
|
mg |
| 030
5073 |
5
|
mg |
[2H6]2-METHYLTHIO-N6-ISOPENTENYLADENOSINE (D-2MeSiPR) [2-methylthio-6-[2H6](3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]
| MW 387.50; crystalline; purity > 95% (HPLC) |
|
CAS: 1258839-12-1; C16H172H6N5O4S |
|
| 030
5061 |
1 |
mg |
| 030
5062 |
2
|
mg |
| 030
5063 |
5
|
mg |
[15N4]KINETIN(15N-K) [6-furfurylamino[15N4]purine]
| MW 219.19;
CRYSTALLINE; purity > 97% (HPLC) |
C10H9N15N4O
|
|
| 030
0341 |
1 |
mg |
| 030
0342 |
2
|
mg |
| 030
0343 |
5
|
mg |
[15N-N4]meta-METHOXYTOPOLIN (15N-MemT) [6-(3-methoxybenzylamino)[15N4]purine]
| MW 259.25; crystalline; purity > 98% (HPLC) |
|
C13H13N15N4O |
|
| 030
0511 |
1 |
mg |
| 030
0512 |
2
|
mg |
| 030
0513 |
5
|
mg |
[15N4]meta-TOPOLIN (15N-mT) [6-(3-hydroxybenzylamino)[15N4]purine]
| MW 245.23; CRYSTALLINE; purity >97% (HPLC) |
CAS: 2271138-13-5; C12H11N15N4O
|
|
| 030
0101 |
1 |
mg |
| 030
0102 |
2
|
mg |
| 030
0103 |
5
|
mg |
[15N4]meta-TOPOLIN
RIBOSIDE (15N-mTR) [6-(3-hydroxybenzylamino)-9-b-D-ribofuranosyl[15N4]purine]
| MW 377.34; crystalline;purity >95% (HPLC) |
|
CAS: 2271138-17-9; C17H19N15N4O5 |
|
| 030
0111 |
100 |
µg |
| 030
0112 |
200 |
µg |
| 030
0113 |
500 |
µg |
[15N4]meta-TOPOLIN-9-GLUCOSIDE (15N-mT9G) [6-(3-hydroxybenzylamino)-9-β-D-glucopyranosylpurine[15N4]purine]
| MW 407.37; crystalline; purity > 95% (HPLC) |
|
C18H21N15N4O6 |
|
| 030
0141 |
100 |
µg |
| 030
0142 |
200
|
µg |
| 030
0143 |
500
|
µg |
[15N4]meta-TOPOLIN-7-GLUCOSIDE (15N-mT7G) [6-(3-hydroxybenzylamino)-7-β-D-glucopyranosylpurine[15N4]purine]
| MW 407.37; crystalline; purity > 95% (HPLC) |
|
C18H21N15N4O6 |
|
| 030
7861 |
100 |
µg |
| 030
7862 |
200
|
µg |
| 030
7863 |
500
|
µg |
[15N4]ortho-TOPOLIN (15N-oT) [6-(2-hydroxybenzylamino)[15N4]purine]
| MW 245.23; CRYSTALLINE; purity >98% (HPLC) |
CAS: 2271138-12-4; C12H11N15N4O
|
|
| 030
0121 |
1 |
mg |
| 030
0122 |
2
|
mg |
| 030
0123 |
5
|
mg |
[15N4]ortho-TOPOLIN
RIBOSIDE (15N-oTR) [6-(2-hydroxybenzylamino)-9-b-D-ribofuranosyl[15N4]purine]
| MW 377.34; crystalline;purity >95% (HPLC) |
|
CAS: 2271138-16-8; C17H19N15N4O5 |
|
| 030
0131 |
100 |
µg |
| 030
0132 |
200 |
µg |
| 030
0133 |
500 |
µg |
[15N4]ortho-TOPOLIN-9-GLUCOSIDE (15N-oT9G) [6-(2-hydroxybenzylamino)-9-β-D-glucopyranosylpurine[15N4]purine]
| MW 407.37; crystalline; purity > 95% (HPLC) |
|
CAS: 2271138-03-3; C18H21N15N4O6 |
|
| 030
0151 |
100 |
µg |
| 030
0152 |
200
|
µg |
| 030
0153 |
500
|
µg |
[15N4]ortho-TOPOLIN-7-GLUCOSIDE (15N-oT7G) [6-(2-hydroxybenzylamino)-7-β-D-glucopyranosylpurine[15N4]purine]
| MW 407.37; crystalline; purity > 95% (HPLC) |
|
C18H21N15N4O6 |
|
| 030
7871 |
100 |
µg |
| 030
7872 |
200
|
µg |
| 030
7873 |
500
|
µg |
[15N4]para-TOPOLIN (15N-pT) [6-(4-hydroxybenzylamino)[15N4]purine]
| MW 245.23; CRYSTALLINE; purity >98% (HPLC) |
CAS: 2271138-14-6; C12H11N15N4O
|
|
| 030
0451 |
1 |
mg |
| 030
0452 |
2
|
mg |
| 030
0453 |
5
|
mg |
[15N4]para-TOPOLIN
RIBOSIDE (15N-mTR) [6-(4-hydroxybenzylamino)-9-b-D-ribofuranosyl[15N4]purine]
| MW 377.34; crystalline;purity >95% (HPLC) |
|
CAS: 2271138-18-0; C17H19N15N4O5 |
|
| 030
0461 |
100 |
µg |
| 030
0462 |
200 |
µg |
| 030
0463 |
500 |
µg |
[15N4]para-TOPOLIN-9-GLUCOSIDE (15N-pT9G) [6-(4-hydroxybenzylamino)-9-β-D-glucopyranosylpurine[15N4]purine]
| MW 407.37; crystalline; purity > 95% (HPLC) |
|
CAS: 2271138-05-5; C18H21N15N4O6 |
|
| 030
0401 |
100 |
µg |
| 030
0402 |
200
|
µg |
| 030
0403 |
500
|
µg |
[15N4]para-TOPOLIN-7-GLUCOSIDE (15N-pT7G) [6-(4-hydroxybenzylamino)-7-β-D-glucopyranosylpurine[15N4]purine]
| MW 407.37; crystalline; purity > 90% (HPLC) |
|
C18H21N15N4O6 |
|
| 030
7881 |
100 |
µg |
| 030
7882 |
200
|
µg |
| 030
7883 |
500
|
µg |
[2H5]trans-ZEATIN (D-tZ)[6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)purine]
| MW 224.28; crystalline; purity > 98% (HPLC); cis isomer < 5% |
CAS: 72963-19-0; C10H82H5N5O
|
|
| 030
0301 |
1 |
mg |
| 030
0302 |
2
|
mg |
| 030
0303 |
5 |
mg |
[15N]trans-ZEATIN (15N-tZ) [6-((E)-4-hydroxy-3-methylbut-2-enylamino) purine]
| MW 220.24;
crystalline; purity > 98% (HPLC) |
|
C10H13N415NO |
|
| 030
7041 |
1 |
mg |
| 030
7042 |
2 |
mg |
| 030
7043 |
5 |
mg |
[15N4]trans-ZEATIN (15N4-tZ) [6-[15N4]((E)-4-hydroxy-3-methylbut-2-enylamino) purine]
| MW 223.22;
crystalline; purity > 98% (HPLC) |
|
CAS: 77900-28-8; C10H1315N4NO |
|
| 030
7381 |
1 |
mg |
| 030
7382 |
2 |
mg |
| 030
7383 |
5 |
mg |
[2H5]trans-ZEATIN RIBOSIDE (D-tZR) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]
| MW 356.40; crystalline; purity > 97% (HPLC); cis isomer < 0.2% |
|
CAS: 72963-21-4; C15H162H5N5O5 |
|
| 030
0311 |
1 |
mg |
| 030
0312 |
2 |
mg |
| 030
0313 |
5 |
mg |
[2H5]trans-ZEATIN-7-GLUCOSIDE (D-tZ7G) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-7-β-D-glucopyranosylpurine]
| MW 386.42;
crystalline; purity > 95% (HPLC) |
|
C16H182H5N5O6 |
|
| 030
5111 |
1 |
mg |
| 030
5112 |
2
|
mg |
| 030
5113 |
5 |
mg |
[15N4]trans-ZEATIN-9-GLUCOSIDE (15N-tZ9G) [6-((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosyl[15N4]purine]
| MW
385.36;
crystalline; purity > 95% (HPLC) |
|
CAS: 2271138-02-2; C16H23N15N4O6 |
|
| 030
7891 |
100 |
µg |
| 030
7892 |
200 |
µg |
| 030
7893 |
500 |
µg |
[2H5]trans-ZEATIN-9-GLUCOSIDE (D-tZ9G) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosylpurine]
| MW 386.42;
crystalline; purity > 95% (HPLC) |
|
CAS: 84744-92-3; C16H182H5N5O6 |
|
| 030
0471 |
1 |
mg |
| 030
0472 |
2 |
mg |
| 030
0473 |
5 |
mg |
[2H5]trans-ZEATIN-O-GLUCOSIDE (D-tZOG) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-O-β-D-glucopyranosylpurine]
| MW 386.42;
crystalline; purity > 95% (HPLC) |
|
CAS: 72963-23-6; C16H182H5N5O6 |
|
| 030
5121 |
1 |
mg |
| 030
5122 |
2
|
mg |
| 030
5123 |
5
|
mg |
[2H5]trans-ZEATIN-O-GLUCOSIDE RIBOSIDE (D-tZROG) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosyl-O-β-D-glucopyranosylpurine]
| MW 518.54; crystalline; purity > 95% (HPLC) |
|
CAS: 69700-29-4; C21H262H5N5O10 |
|
| 030
5131 |
1 |
mg |
| 030
5132 |
2
|
mg |
| 030
5133 |
5
|
mg |
[2H5]trans-ZEATIN RIBOSIDE-5'-MONOPHOSPHATE (D-tZMP) [6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]
| MW 498.29; crystalline; purity > 95% (HPLC) |
|
C15H152H5N5Na2O8P.H2O |
|
| 030
5141 |
1 |
mg |
| 030
5142 |
2
|
mg |
| 030
5143 |
5
|
mg |
[2H5]2-METHYLTHIO-trans-ZEATIN (D-2MetSZ) [2-methylthio-6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)purine]
| MW 270.37; crystalline; purity > 95% (HPLC) |
|
CAS:1258839-09-6; C11H102H5N5OS |
|
| 030
5171 |
1 |
mg |
| 030
5172 |
2
|
mg |
| 030
5173 |
5
|
mg |
[2H5]2-METHYLTHIO-trans-ZEATIN RIBOSIDE (D-2MeStZR) [2-methylthio-6-[2H5]((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]
| MW 402.49; crystalline; purity > 95% (HPLC) |
|
CAS: 1258839-10-9; C16H182H5N5O5S |
|
| 030
5181 |
1 |
mg |
| 030
5182 |
2
|
mg |
| 030
5183 |
5
|
mg |
[15N4]cis-ZEATIN (15N-cZ) [6-[15N4]((Z)-4-hydroxy-3-methylbut-2-enylamino) purine]
| MW 223.22;
crystalline; purity > 98% (HPLC) |
|
CAS: 2271138-11-3; C10H13N15N4O |
|
| 030
0321 |
1 |
mg |
| 030
0322 |
2 |
mg |
| 030
0323 |
5 |
mg |
[15N4]cis-ZEATIN RIBOSIDE (cZR) [6-((Z)-4-hydroxy-3-methylbut-2-enylamino)-9-b-D-ribofuranosyl[15N4]purine]
| MW 355.34; crystalline; purity > 95% (HPLC) |
|
CAS: 2271138-15-7; C15H21N15N4O5 |
|
| 030
0331 |
100 |
µg |
| 030
0332 |
200 |
µg |
| 030
0333 |
500 |
µg |
[15N4]cis-ZEATIN-9-GLUCOSIDE (15N-cZ9G) [6-((Z)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosyl[15N4purine]
| MW
385.36;
crystalline; purity > 95% (HPLC) |
|
CAS: 2271138-01-1; C16H23N15N4O6 |
|
| 030
2891 |
100 |
µg |
| 030
2892 |
200 |
µg |
| 030
2893 |
500 |
µg |
[15N4]cis-ZEATIN-7-GLUCOSIDE (15N-cZ7G) [6-((Z)-4-hydroxy-3-methylbut-2-enylamino)-7-β-D-glucopyranosyl[15N4]purine]
| MW
385.36;
crystalline; purity > 95% (HPLC) |
|
CAS: 2271138-01-1; C16H23N15N4O6 |
|
| 030
7851 |
100 |
µg |
| 030
7852 |
200 |
µg |
| 030
7853 |
500 |
µg |